Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding
Study Details
Study Description
Brief Summary
In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. This experimental study was conducted with patients who applied to UroKlinik in Istanbul between March 2021 and June 2023 and were diagnosed with dysfunctional voiding. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form and Uroflowmetry test were applied to all participants before and at week 6.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Dynamic Neuromuscular Stabilisation Exercise The participants performed DNS exercises addition to standard therapy |
Other: Exercise
Dynamic Neuromuscular Stabilisation Exercise
Other: Standard therapy
Patient education, massage, diaphragmatic breathing, kegel exercise
|
| Other: Standard therapy Patient education, massage, diaphragmatic breathing, kegel exercise |
Other: Standard therapy
Patient education, massage, diaphragmatic breathing, kegel exercise
|
Outcome Measures
Primary Outcome Measures
- Uroflowmetry - Maximum flow rate (Qmax) [at the baseline and at week 6.]
Uroflowmetry gives information about urine flow rate and voiding pattern. *Qmax (mL/s): Qmax is the fastest stream measured in mL/s.
- Uroflowmetry - Average flow rate (Qave) [at the baseline and at week 6.]
Uroflowmetry gives information about urine flow rate and voiding pattern. *Qave (mL/s): Qave is the average stream measured in mL/s.
- Uroflowmetry - Corrected maximum flow rate (cQmax) [at the baseline and at week 6.]
Uroflowmetry gives information about urine flow rate and voiding pattern. *cQmax (mL/s/√ mL): cQmax is the precise assessment of fastest stream, especially at high volumes. Is it estimated Qmax/√ VV.
- Uroflowmetry - Flow time (FT) [at the baseline and at week 6.]
Uroflowmetry gives information about urine flow rate and voiding pattern. *FT (s): FT is the time over which measurable flow actually occurs.
- Uroflowmetry - Voiding volume (VV) [at the baseline and at week 6.]
Uroflowmetry gives information about urine flow rate and voiding pattern. *VV (ml): VV indicates the amount of voiding.
- Uroflowmetry - Residual urine (RU) [at the baseline and at week 6.]
Uroflowmetry gives information about urine flow rate and voiding pattern. *RU (ml): RU is the amount of urine that is left behind in the bladder after you are done urinating.
- Dysfunctional Voiding and Incontinence Symptom Score [at the baseline and at week 6.]
It gives information about voiding and incontinence symptoms. The questionnaire contains fourteen questions about symptoms and quality of life. The total score ranges from 0 to 35 and a score above 8.5 indicates abnormalities.
- Short Form 36 [at the baseline and at week 6.]
It gives information about health related quality of life. The total score of the scale ranges from 0 to 100, and a high score indicates a high quality of life.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Having been diagnosed with dysfunctional voiding,
-
Being between the ages of 18-75,
-
Not having a neurogenic bladder
-
Not having a urinary tract infection
-
Not having an obstacle to exercise,
-
Accepting and signing the Approval Form,
-
Not having undergone surgery in the last 6 months,
Exclusion Criteria:
-
Not being cooperative
-
Not being able to participate in the treatment,
-
The use of drugs that will affect urination
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Haliç University | Istanbul | Turkey |
Sponsors and Collaborators
- Halic University
Investigators
- Study Director: Seda Saka, PhD, Haliç University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ssaka8